| Literature DB >> 27973451 |
Meng-Tsan Tsai1,2,3, Ting-Yen Tsai4, Su-Chin Shen5,6, Chau Yee Ng7,8, Ya-Ju Lee9, Jiann-Der Lee10,11, Chih-Hsun Yang12,13.
Abstract
The nail provides a functional protection to the fingertips and surrounding tissue from external injuries. The nail plate consists of three layers including dorsal, intermediate, and ventral layers. The dorsal layer consists of compact, hard keratins, limiting topical drug delivery through the nail. In this study, we investigate the application of fractional CO₂ laser that produces arrays of microthermal ablation zones (MAZs) to facilitate drug delivery in the nails. We utilized optical coherence tomography (OCT) for real-time monitoring of the laser-skin tissue interaction, sparing the patient from an invasive surgical sampling procedure. The time-dependent OCT intensity variance was used to observe drug diffusion through an induced MAZ array. Subsequently, nails were treated with cream and liquid topical drugs to investigate the feasibility and diffusion efficacy of laser-assisted drug delivery. Our results show that fractional CO₂ laser improves the effectiveness of topical drug delivery in the nail plate and that OCT could potentially be used for in vivo monitoring of the depth of laser penetration as well as real-time observations of drug delivery.Entities:
Keywords: drug delivery; fractional laser; laser ablation; nail; optical coherence tomography
Mesh:
Year: 2016 PMID: 27973451 PMCID: PMC5191091 DOI: 10.3390/s16122111
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1In vivo (a–d) top-view and (e–h) representative cross-sectional OCT images of four fingernails after fractional laser exposures to (from left to right) energies of 50, 40, 30, and 20 mJ. The red-dash lines in (a–d) indicate the corresponding locations of (e–h).
Figure 2Time-series 2D OCT images obtained at the same location of the fingernail after 50 mJ fractional laser exposure. OCT images obtained (a) before the liquid drug application and at (b) 0 s; (c) 0.2 s; (d) 0.4 s; (e) 0.6 s; (f) 0.8 s; (g) 1.0 s; (h) 2.0 s; (i) 4.0 s; (j) 6.0 s; (k) 8.0 s; and (l) 10.0 s after the liquid drug application. The white arrows indicate that the stronger OCT backscattered signal resulted from the aggregation of drug particles. The yellow arrow indicates the nail bed. The yellow and white lines indicate the locations for estimation of the averaged A-scan profiles of the unexposed and treated regions.
Figure 3(a) Averaged A-scan profiles of the yellow line (the unexposed region) in Figure 2 and (b) the averaged A-scan profiles of the white line (the exposed region) in Figure 2 obtained at time points of 0, 2.0, 4.0, 6.0, 8.0, and 10.0 s after the drug application. The black arrows indicate the variation in OCT backscattered intensity after the drug application.
Figure 4(a) 2D OCT image of the nail after 50 mJ laser exposure. Time-series SV-OCT images of the treated nail obtained after the liquid drug application at (b) 0 s; (c) 0.2 s; (d) 0.4 s; (e) 0.6 s; (f) 0.8 s; (g) 1.0 s; (h) 2.0 s; (i) 4.0 s; (j) 6.0 s; (k) 8.0 s; and (l) 10.0 s. The white arrows indicate the stronger backscattered signal, resulting from the drug particles. The scalar bar in (l) represents a length of 500 μm in length.
Figure 5(a) 2D OCT image of the nail after fractional laser exposure with an exposure energy of 50 mJ. Time-series SV-OCT images of the nail obtained at (b) 0 s; (c) 0.2 s; (d) 0.4 s; (e) 0.6 s; (f) 0.8 s; (g) 1.0 s; (h) 2.0 s; (i) 4.0 s; (j) 6.0 s; (k) 8.0 s; and (l) 10.0 s after the cream drug application. The white arrows indicate that the MAZs were filled with the cream drug. The scalar bar in (l) represents a length of 500 μm in length.
Figure 6(a) Averaged summation of SV values of Regions I, II, and III indicated by the squares in Figure 4 as a function of time; (b) Averaged summation of SV values of Regions I, II, and III indicated by the squares in Figure 5 as a function of time.